Oncology & Anticancer

DexrazoxaneThird Party Manufacturing in India

Looking to get Dexrazoxane manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.

WHO-GMP Certified
Export Ready
PCD Franchise Available
CAS Number
24584-09-6
Drug Class
Cardioprotective agent / Topoisomerase II inhibitor
Molecular Formula
C₁₁H₁₆N₄O₄
Molecular Weight
268.27 g/mol
Grade Standards
IP, USP
Therapeutic Category
Oncology & Anticancer
MOQ
1,000 vials per batch
Dosage Forms
Dry Injection

Mechanism of Action

Dexrazoxane works by diffusing into cardiac cells and undergoing intracellular hydrolysis to form an active iron-chelating metabolite. It inhibits the formation of toxic anthracycline-iron complexes and free radicals to help the body protect myocardial tissues from oxidative damage. Unlike alternative antioxidants, it specifically disrupts topoisomerase II complexes to provide targeted cardioprotection during chemotherapy. Our partner networks guarantee high chemical specifications. It is highly effective and well-tolerated.

Therapeutic Uses & Indications

Therapeutic Uses

  • Anthracycline Cardioprotection: Protects cardiac tissue in advanced breast cancer patients receiving high-cumulative doxorubicin therapy.
  • Extravasation Management: Administered urgently to treat accidental intravenous extravasation of anthracyclines.
  • Myocardial Defense: Minimizes long-term cardiomyopathy risks during intense oncology treatment cycles.

Why Manufacturers Choose Dexrazoxane

Dexrazoxane is a highly specialized oncology supportive care drug with limited market competition. Sourcing through Dexrazoxane third party manufacturing in India enables oncology marketers to broaden their specialty portfolios with high-value therapeutic solutions. The manufacturing lines managed by our partner networks strictly fulfill international WHO-GMP protocols. Comprehensive analytical documentation under CAS 24584-09-6 is provided to ensure complete global regulatory acceptance.

Dosage Forms We Manufacture

Dry Injection
250mg · 500mg

Frequently Asked Questions

What is the minimum order quantity for Dexrazoxane?
Minimum order quantity for Dexrazoxane is 1,000 vials per batch. Please contact us for bulk pricing and custom quantities.
What dosage forms of Dexrazoxane can you manufacture?
We manufacture Dexrazoxane as: Dry Injection (250mg, 500mg).
Are your manufacturing facilities WHO-GMP certified?
Yes. Celesta Healthcare works exclusively with WHO-GMP certified partner production facilities. All manufacturing batches are subject to strict quality control and documentation.
Can you manufacture Dexrazoxane for export?
Yes. We provide export-ready Dexrazoxane formulations structured across 25+ countries. We provide full export documentation including Certificate of Analysis (CoA), Certificate of Origin, and regulatory dossiers on request.
What grade standards do you follow for Dexrazoxane?
We manufacture Dexrazoxane to IP, USP pharmacopoeial standards.
Third Party Manufacturing

Get Dexrazoxane made under your brand

  • WHO-GMP certified facilities
  • Quote within 24 hours
  • MOQ from 1,000 vials per batch
Get a Manufacturing QuoteWhatsApp Us Now

+91 9689237122 · replies within hours

Our Manufacturing Capabilities

  • WHO-GMP Certified Partner Plants
  • 25+ years of pharma industry experience
  • PCD Franchise with monopoly rights
  • Export support across 25+ countries
  • Small batch to commercial scale
  • Custom formulation development

Packaging Options

Lyophilized type-I glass vials in secure clinical packaging. Packaging customized to client brand guidelines.

Start Manufacturing Dexrazoxane Today

Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Dexrazoxane across all dosage forms. PCD franchise and export orders welcome.

Need something? Chat with us!